21 hours ago · Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic ...
Nov 20, 2024 · The EBMT will be actively participating in the 66th ASH Annual Meeting & Exposition that will take place December 7-10, 2024, in San Diego, California, ...
Missing: syndromes | Show results with:syndromes
6 days ago · The putative different requirements for graft-versus-leukemia dynamics in acute leukemia and chronic malignancies, as well as for myeloid and lymphoid disorders ...
Missing: Haematopoietic Leukaemia
Nov 13, 2024 · ... Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party
Nov 12, 2024 · ... Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome (DR. DREAM), a Phase I Trial. Apperley, J. 1104 ...
Nov 13, 2024 · Allogeneic bone marrow transplantation remains the most potent curative therapy for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) due to the ...
Nov 11, 2024 · Hematopoietic stem cell transplants, including peripheral blood, bone marrow, and cord blood transplants are used most often to treat cancers affecting the ...
Nov 11, 2024 · Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment option for patients with refractory and relapsed acute ...
Missing: Haematopoietic | Show results with:Haematopoietic
Nov 16, 2024 · The aim of this retrospective, EBMT registry-based study was to determine outcome differences for chronic myeloid malignancies and secondary acute myeloid ...
Missing: Haematopoietic Leukaemia
Nov 14, 2024 · The report by Li and colleagues investigates determinants of evolution to myelodysplastic syndrome and acute myeloid leukaemia in patients with aplastic anaemia ...